Tazeen Ahmad Analyst PerformanceManaging Director at Bank of AmericaTazeen Ahmad is a stock analyst at Bank of America in the medical sector, covering 29 publicly traded companies. Over the past year, Tazeen Ahmad has issued 45 stock ratings, including buy, hold, and sell recommendations. While full access to Tazeen Ahmad's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tazeen Ahmad's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings74 Last 10 YearsBuy Recommendations64.86% 48 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution74RatingsDistribution of strong buy, buy, hold, and sell ratings by Tazeen Ahmad.RatingPercentageCount Strong Buy0.0%0 ratings Buy64.9%48 ratings Hold18.9%14 ratings Sell16.2%12 ratingsOut of 74 total stock ratings issued by Tazeen Ahmad at Bank of America, the majority (64.9%) have been Buy recommendations, followed by 18.9% Hold and 16.2% Sell.Best & Worst CallsBest Call0000.0%FDMTMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BCRXJun 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.6% of companies on NASDAQ28 companiesNYSE3.4% of companies on NYSE1 companyTazeen Ahmad, an analyst at Bank of America, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical29 companies100.0%Tazeen Ahmad of Bank of America specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE24 companies82.8%MED - DRUGS3 companies10.3%MED - GENERIC DRG1 company3.4%BIOTECHNOLOGY1 company3.4% About Tazeen AhmadTazeen Ahmad is a Managing Director in US Equity Research covering small and mid-cap Biotechnology. She joined the firm in 2009 as an associate on the large-cap pharmaceuticals team and transitioned to biotech in 2010. She assumed the role of senior SMID Biotech analyst in 2015. She has consistently ranked at the top of the II poll in smid biotech since 2017. Previously, she was an associate at Citigroup on the large-cap pharma team. She has a bachelor’s degree in biology from Harvard University and is based in New York. Tazeen Ahmad's Ratings History at Bank of America Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsASNDAscendis Pharma A/S4/16/2026Boost Price Target$239.69$292.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals3/25/2026Upgrade$20.96$29.00Buy$0.0000.00% ROIBCAXBicara Therapeutics3/25/2026Initiated Coverage$18.16$35.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals3/17/2026Lower Price Target$90.51$139.00Buy$0.0000.00% ROIASNDAscendis Pharma A/S3/5/2026Reiterated Rating$237.35$262.00Buy$0.0000.00% ROIPTCTPTC Therapeutics2/20/2026Lower Price Target$69.90$93.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/12/2026Reiterated Rating$309.74Buy$0.0000.00% ROIASNDAscendis Pharma A/S1/30/2026Boost Price Target$223.95$260.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/30/2026Lower Price Target$346.79$462.00Buy$0.0000.00% ROIBLTEBelite Bio1/26/2026Initiated Coverage$164.57$195.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. APLSApellis Pharmaceuticals1/21/2026Upgrade$20.47$28.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/12/2026Lower Price Target$359.24$529.00Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical1/2/2026Lower Price Target$23.17$58.00Buy$0.0000.00% ROIKYMRKymera Therapeutics12/9/2025Boost Price Target$94.30$112.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics12/9/2025Boost Price Target$14.68$7.00Underperform$0.0000.00% ROIPHVSPharvaris12/4/2025Boost Price Target$29.36$30.00Neutral$0.0000.00% ROIBNTXBioNTech10/22/2025Lower Price Target$106.23$130.00Buy$0.0000.00% ROISRPTSarepta Therapeutics10/22/2025Boost Price Target$21.66$18.00Underperform$0.0000.00% ROISRRKScholar Rock10/9/2025Initiated Coverage$38.69$53.00Buy$0.0000.00% ROIPHVSPharvaris10/9/2025Upgrade$22.98$27.00Neutral$0.0000.00% ROIALNYAlnylam Pharmaceuticals9/17/2025Boost Price Target$462.37$520.00Buy$0.0000.00% ROIINCYIncyte9/4/2025Boost Price Target$85.57$104.00Buy$0.0000.00% ROIASNDAscendis Pharma A/S9/2/2025Boost Price Target$201.91$230.00Buy$0.0000.00% ROIARGXargenex9/2/2025Boost Price Target$705.29$887.00Buy$0.0000.00% ROIPTCTPTC Therapeutics8/20/2025Lower Price Target$49.59$76.00Buy$0.0000.00% ROISRPTSarepta Therapeutics8/20/2025Boost Price Target$20.18$17.00Underperform$0.0000.00% ROIBNTXBioNTech8/5/2025Boost Price Target$110.04$134.00Buy$0.0000.00% ROIPTCTPTC Therapeutics7/29/2025Boost Price Target$49.02$84.00Buy$0.0000.00% ROISRPTSarepta Therapeutics7/23/2025Reiterated Rating$13.61Underperform$0.0000.00% ROISRPTSarepta Therapeutics7/18/2025Lower Price Target$18.20$20.00Neutral$0.0000.00% ROIAPLSApellis Pharmaceuticals7/16/2025Boost Price Target$19.35$24.00Neutral$0.0000.00% ROIBNTXBioNTech7/16/2025Lower Price Target$110.65$126.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals7/11/2025Boost Price Target$322.64$359.00Buy$0.0000.00% ROITSHATaysha Gene Therapies7/11/2025Initiated Coverage$2.55$8.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals7/10/2025Boost Price Target$88.44$95.00Buy$0.0000.00% ROIBCRXBioCryst Pharmaceuticals7/1/2025Boost Price Target$9.00$15.00Buy$0.0000.00% ROISRPTSarepta Therapeutics6/16/2025Reiterated Rating$18.52$28.00Neutral$0.0000.00% ROIASNDAscendis Pharma A/S6/9/2025Boost Price Target$174.41$216.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals6/5/2025Boost Price Target$21.77$23.00Hold$0.0000.00% ROIASNDAscendis Pharma A/S6/3/2025Boost Price Target$175.69$201.00Buy$0.0000.00% ROIPRTAProthena5/28/2025Reiterated Rating$4.58Underperform$0.0000.00% ROISTROSutro Biopharma5/19/2025Lower Price Target$8.63$8.00Underperform$0.0000.00% ROIDNLIDenali Therapeutics5/19/2025Lower Price Target$13.90$27.00Buy$0.0000.00% ROIPTCTPTC Therapeutics5/9/2025Upgrade$42.54$68.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals5/9/2025Downgrade$17.88$23.00Neutral$0.0000.00% ROIRYTMRhythm Pharmaceuticals4/7/2025Upgrade$52.80$63.00Buy$00.0000.00% ROIALNYAlnylam Pharmaceuticals3/21/2025Boost Price Target$253.60$325.00Buy$000.0000.00% ROISTROSutro Biopharma3/14/2025Downgrade$12.50$10.00Underperform$00.0000.00% ROIARVNArvinas3/12/2025Lower Price Target$8.30$28.00Buy$00.0000.00% ROIPTCTPTC Therapeutics3/11/2025Upgrade$52.49$55.00Neutral$00.0000.00% ROIMRUSMerus3/10/2025Lower Price Target$45.98$70.00Buy$0.0000.00% ROIFDMT4D Molecular Therapeutics3/10/2025Lower Price Target$3.92$40.00Buy$0.0000.00% ROIDNLIDenali Therapeutics3/10/2025Lower Price Target$15.17$28.00Buy$00.0000.00% ROINBIXNeurocrine Biosciences2/7/2025Lower Price Target$150.51$179.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenMorgan StanleyRoyal Bank Of CanadaBerenberg BankUBS GroupCitigroupBarclaysWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
